Rezafungin

CHEBI:CHEBI_749932

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
rezafungin
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
active_ingredient_strength
200 mg/1
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_start_date
20230609
package_marketing_start_date
09-JUN-23
labeler_name
Melinta Therapeutics, LLC
pharm_class_epc
Echinocandin Antifungal [EPC]
pharm_class
Lipopeptides [CS]
pharm_class_cs
Lipopeptides [CS]
nui
N0000175507
manufacturer_name
Melinta Therapeutics, LLC
product_ndc
70842-240
spl_id
4714cf42-4658-4261-b828-828c5c254ac8
active_ingredient_name
REZAFUNGIN
package_ndc
70842-240-01
package_description
1 VIAL in 1 CARTON (70842-240-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
brand_name
REZZAYO
brand_name_base
REZZAYO
application_number
NDA217417
rxcui
2639165
unii
G013B5478J
spl_set_id
90073508-6dca-4d27-aa5a-ed837737c35b
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class